MARKET

ICLR

ICLR

ICON PLC
NASDAQ

Real-time Quotes | Nasdaq Last Sale

269.96
+1.23
+0.46%
After Hours: 269.96 0 0.00% 17:06 09/21 EDT
OPEN
269.23
PREV CLOSE
268.73
HIGH
271.44
LOW
268.00
VOLUME
319.24K
TURNOVER
--
52 WEEK HIGH
271.51
52 WEEK LOW
168.76
MARKET CAP
21.49B
P/E (TTM)
39.54
1D
5D
1M
3M
1Y
5Y
Should You Think About Buying ICON Public Limited Company (NASDAQ:ICLR) Now?
ICON Public Limited Company ( NASDAQ:ICLR ) saw a significant share price rise of over 20% in the past couple of months...
Simply Wall St. · 2d ago
Where Icon Stands With Analysts
Over the past 3 months, 5 analysts have published their opinion on Icon (NASDAQ:ICLR) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upc...
Benzinga · 09/14 16:38
Jefferies Maintains Buy on Icon, Raises Price Target to $302
Jefferies analyst David Windley maintains Icon (NASDAQ:ICLR) with a Buy and raises the price target from $276 to $302.
Benzinga · 09/14 13:56
Jefferies Adjusts ICON PT to $302 from $276, Keeps Buy Rating
MT Newswires · 09/14 12:38
Research Alert: CFRA Lowers Opinion On Shares Of Icon Plc To Hold From Buy
MT Newswires · 09/10 11:26
ICON plc to Present at the Wells Fargo 16th Annual Healthcare Conference and the Baird Global Healthcare Conference
DUBLIN, September 02, 2021--ICON plc to Present at the Wells Fargo 16th Annual Healthcare Conference and the Baird Global Healthcare Conference
Business Wire · 09/02 10:00
PFM Health Sciences, LP Buys Seagen Inc, Centene Corp, ACADIA Pharmaceuticals Inc, Sells PPD ...
GuruFocus News · 08/24 15:38
Lingohr & Partner Asset Management GmbH Buys Stellantis NV, West Fraser Timber Co. ...
GuruFocus News · 08/23 16:38
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ICLR. Analyze the recent business situations of ICON PLC through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 15 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ICLR stock price target is 255.23 with a high estimate of 302.00 and a low estimate of 225.00.
EPS
Institutional Holdings
Institutions: 750
Institutional Holdings: 93.54M
% Owned: 117.53%
Shares Outstanding: 79.59M
TypeInstitutionsShares
Increased
224
12.76M
New
91
6.15M
Decreased
199
9.46M
Sold Out
67
1.14M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+1.43%
Pharmaceuticals & Medical Research
+0.74%
Key Executives
Non-Executive Chairman/Director
Ciaran Murray
Chief Financial Officer/Executive Board/IR Contact Officer
Brendan Brennan
Executive Vice President/Chief Administrative Officer/General Counsel/Secretary
Diarmaid Cunningham
Lead Director/Independent Director
Ronan Murphy
Independent Director
Hugh Brady
Independent Director
John Climax
Independent Director
Joan Garahy
Independent Director
William Hall
Independent Director
Eugene McCague
Independent Director
Julie O'Neill
Independent Director
Mary Pendergast
No Data
About ICLR
ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies. Its services include clinical trials management, biometric activities, consulting, imaging, contract staffing, informatics and laboratory services. The Company's information systems offerings include ICONIK, Firecrest, ADDPLAN, AptivAdvantage and Aptiv Insite. It conducts various laboratory tests on the patient's blood, urine and other bodily fluids at appropriate intervals during the trial. The Company offers clinical development services, including investigator recruitment, patient registries, outcomes research, clinical data management, immunoassay development and others.

Webull offers kinds of ICON PLC stock information, including NASDAQ:ICLR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ICLR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ICLR stock methods without spending real money on the virtual paper trading platform.